Liminatus Pharma, Inc. Warrants share price logo

Liminatus Pharma, Inc. Warrants

NASDAQ: LIMNW

$0.04

-0.00

(-7.94%)

Live

as on

Liminatus Pharma, Inc. Warrants Stock Performance

as on October 24, 2026 at 12:45 am IST

  • $0.04
    $0.04

  • 52 Week's Low

    52 Week's High

    $0.03
    $0.19
    downward going graph

    25.00%

    Downside

    387.25%

    Upside

    downward going graph

Liminatus Pharma, Inc. Warrants share price movements today

Previous Close
$0.04
Open
$0.04
Volume
204.0
Day's Low - High
$0.04 - $0.04
52 Week Low - High
$0.03 - $0.19

Liminatus Pharma, Inc. Warrants Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Liminatus Pharma, Inc. Warrants Stock Fundamentals & Key Indicators

Check Liminatus Pharma, Inc. Warrants market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0.00

Return On Equity TTM

0.00%

Liminatus Pharma, Inc. Warrants stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Liminatus Pharma, Inc. Warrants with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Liminatus Pharma, Inc. Warrants image
Liminatus Pharma, Inc. Warrants
NA$-NANA0.00%0.00%

Indian Investors' Interest in Liminatus Pharma, Inc. Warrants Stock

Search interest for Liminatus Pharma, Inc. Warrants Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-67% versus previous 30 day period

Liminatus Pharma, Inc. Warrants Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Dec 2024
Mar 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
-
-
0
-
0
0
Operating Income
-1
0
0
0
0
-1
-1
EBITDA
-1
0
0
-1
-8
-1
-1
Interest Expense
0
0
0
0
0
0
0
Depreciation
-
-
-
0
0
0
0
Income Before Tax
-1
0
0
-1
-8
-1
-1
Income Tax Expense
-
0
-
-
-
-
-
Net Income
-1
0
0
-1
-8
-1
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Liminatus Pharma, Inc. Warrants Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Income
-2
-2
-2
-2
EBITDA
-2
-1
-2
-9
Interest Expense
0
0
0
0
Depreciation
-
-
-
0
Income Before Tax
-2
-1
-2
-10
Income Tax Expense
-
0
0
-
Net Income
-2
-1
-2
-10
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Liminatus Pharma, Inc. Warrants Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
0
0
0
-
-1
-8
-1
-1
Operating Cash Flow
0
0
0
0
-8
0
0
-2
0
Investing Cash Flow
1
0
0
0
-
0
0
-
-
Financing Cash Flow
0
0
0
0
10
11
-
3
2
Change in Cash
-1
0
0
0
1
0
0
1
1

Liminatus Pharma, Inc. Warrants Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-2
-4
-2
-10
Operating Cash Flow
0
-3
-3
-9
Investing Cash Flow
263
0
1
0
Financing Cash Flow
5
0
1
11
Change in Cash
5
-4
0
0

About Liminatus Pharma, Inc. Warrants

Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.
OrganisationLiminatus Pharma, Inc. Warrants
Headquarters12611 Hiddencreek Way, Cerritos, CA, United States, 90703
IndustryMiscellaneous
CEOMr. Chris Kim J.D., L.L.M.

Key Management of Liminatus Pharma, Inc. Warrants

Name

Title

Mr. Chris Kim J.D., L.L.M.

CEO, Chairman & President

Mr. Scott Dam

Chief Financial Officer

Dr. Beom Kyu Choi

Chief Technology Officer & Member of Scientific Advisory Board

Dr. Byong Chul Yoo Ph.D.

Chief Science Officer & Member of Scientific Advisory Board

FAQs

What is Liminatus Pharma, Inc. Warrants share price today?

Liminatus Pharma, Inc. Warrants share price today is $0.04 as on . Liminatus Pharma, Inc. Warrants share today touched a day high of $0.04 and a low of $0.04.

What is the 52 week high and 52 week low for Liminatus Pharma, Inc. Warrants share?

Liminatus Pharma, Inc. Warrants share touched a 52 week high of $0.19 on and a 52 week low of $0.03 on . Liminatus Pharma, Inc. Warrants stock price today i.e. is trending at $0.04,which is 79.48% down from its 52 week high and 33.33% up from its 52 week low.

How to invest in Liminatus Pharma, Inc. Warrants Stock (LIMNW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Liminatus Pharma, Inc. Warrants on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Liminatus Pharma, Inc. Warrants Stock (LIMNW) from India?

Indian investors can start investing in Liminatus Pharma, Inc. Warrants (LIMNW) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Liminatus Pharma, Inc. Warrants stock (as per the Rupee-Dollar exchange rate as on ). Based on Liminatus Pharma, Inc. Warrants share’s latest price of $0.04 as on October 23, 2026 at 7:15 pm IST, you will get 250.0000 shares of Liminatus Pharma, Inc. Warrants. Learn more about fractional shares .